News

Anticancer-Fund-supported-EFFECT-study

Concentratie van complexe kankerzorg redt levens

New Belgian research, funded by the Anticancer Fund and Kom op tegen Kanker, demonstrated that patients with uterine cancer have a significantly better survival rate when treated in hospitals with sufficient experience and expertise. These findings come from the EFFECT study, led by Prof. Dr. Frédéric Amant (University Hospital Leuven), and emphasize the importance of concentrating complex cancer care in specialized centers.

(news release in Dutch)

Investigators of the PIONEER trial

Hot flush treatment has anti-breast cancer activity, study finds

A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast cancer, a trial coordinated by the University of Cambridge has found.

ACF Trial Transparency Policy

Drug Repurposing as a Source of Innovative Therapies in Cervical Cancer

Presented at the European Society of Gynaecological Oncology Annual Conference 2021 in Prague

How to capture real-world data to prove efficacy of repurposed drugs?

METRO-PD1: A Phase I Feasibility Study Evaluating Anti-PD1 (NIVOLUMAB) In Combination With Metronomic Chemotherapy In Children And Teenagers With Refractory/Relapsing Solid Tumors Or Lymphoma

Presented at SIOP 2021 Congress